Magazine Article | December 1, 2022

Building New Solutions For 2023 In Manufacturing And Supply Chain

Source: Life Science Leader

By Ben Comer, Chief Editor, Life Science Leader

Manufacturing and scaling the spate of new advanced therapeutics in development will continue to present a challenge in 2023, particularly as key supplies and ingredients remain sluggish to procure. Even so, biopharmaceutical executives contributing to this year’s industry outlook evince a confidence about the solutions they have devised from their respective perches along the value chain. In the following Q&A, 11 executives provide their thoughts on what the future holds for biopharmaceutical manufacturing and supply chain operations, and which issues will have the most impact.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader